JERUSALEM--(BUSINESS WIRE)--July 12, 2006--Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA - News) and Eisai Co., Ltd. (Tokyo Stock Exchange/Osaka Securities Exchange: 4523) today announced that they have mutually agreed to end their May 2003 alliance to co-promote Teva’s AZILECT® (rasagiline tablets) for Parkinson’s disease in the United States.
